JosephineFelicianoMD

Oncology • Baltimore, MD

Assistant Professor, Johns Hopkins University

Join to view full profile

Dr. Feliciano is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Feliciano's full profile

Already have an account?

Office
22 S Greene St
Baltimore, MD 21201
Phone+1 410-328-6841

Fax+1 410-328-2578

Education & Training

McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 2008 - 2011
MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 2004 - 2007
Georgetown University School of MedicineClass of 2004

Certifications & Licensure

MD State Medical License 2011 - 2026
IL State Medical License 2008 - 2011
VA State Medical License 2004 - 2008
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib Start of enrollment: 2013 Jun 28
Completed
Phase 3

Publications & Presentations

PubMed

Fecal Microbiome Composition Correlates with Pathologic Complete Response in Patients with Operable Esophageal Cancer Treated with Combined Chemoradiotherapy and Immun...
Fyza Y Shaikh, Seoho Lee, James R White, Yujie Zhao, Jacqueline T Ferri
Cancers. 2024-10-29
3 citations
Telehealth vs In-Person Early Palliative Care for Patients With Advanced Lung Cancer: A Multisite Randomized Clinical Trial.
Joseph A Greer, Jennifer S Temel, Areej El-Jawahri, Simone Rinaldi, Mihir Kamdar
JAMA. 2024-09-11
Dynamic Changes in Circulating Tumor Fraction as a Predictor of Real-World Clinical Outcomes in Solid Tumor Malignancy Patients Treated with Immunotherapy.
Ryan D Gentzler, John Guittar, Akash Mitra, Wade T Iams, Terri Driessen
Oncology and Therapy. 2024-09-01

Journal Articles

Lymph Node Size Predicts for Asymptomatic Brain Metastases in Non-Small Cell Lung Cancer Patients at Diagnosis
Martin J Edelman, Josephine Feliciano, Clinical Lung Cancer

Authored Content

Lymph Node Size Predicts for Asymptomatic Brain Metastases in Non-Small Cell Lung Cancer Patients at DiagnosisSeptember 2018

Press Mentions

Telemedicine Disparities, Adverse Outcomes in Patients with Thoracic CancerJuly 7th, 2022
Opioids, Anxiolytics No Help for Breathlessness in Advanced CancerMarch 1st, 2021
‘But I Never Smoked’: A Growing Share of Lung Cancer Cases Is Turning up in an Unexpected PopulationJanuary 26th, 2021
Join now to see all